Episode Details
Back to Episodes
Discussing axSpA: Biologic therapy outcomes in axial spondyloarthritis
Published 3 weeks ago
Description
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered how certolizumab pegol reduces anterior uveitis flares in high-risk axSpA and the effect of secukinumab dose escalation on MRI inflammation and damage in axSpA.